Patients squeezed in fight over who gets to bill for pricey infusion drugs

Health insurers and medical providers are battling over who should supply high-cost infusion drugs for patients, with the tussle over profits now spilling into statehouses across the country.

Leave A Comment

Your email address will not be published. Required fields are marked *